DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 VMF

2 VMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Calcium chlortetracycline, Chlorotetracycline calcium salt, Calcium-chlortetracycline complex, Chlortetracycline calcium complex, Nr4b2sx17s, Chlortetracycline calcium complex [green book]

Molecular Formula

C₄₄H₄₄CaCl₂N₄O₁₆

Molecular Weight

995.8 g/mol

InChI Key

ZAGFECIBMLCDQK-NAUDNZITSA-L

FDA UNII

NR4B2SX17S

1 2D Structure

UNII-NR4B2SX17S

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

calcium;(4S,4aS,5aS,6S,12aR)-2-carbamoyl-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracen-1-olate

2.1.2 InChI

InChI=1S/2C22H23ClN2O8.Ca/c2*1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21;/h2*4-5,7-8,15,26-27,30,32-33H,6H2,1-3H3,(H2,24,31);/q;;+2/p-2/t2*7-,8-,15-,21-,22-;/m00./s1

2.1.3 InChI Key

ZAGFECIBMLCDQK-NAUDNZITSA-L

2.1.4 Canonical SMILES

CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)[O-])C(=O)N)N(C)C)O.CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)[O-])C(=O)N)N(C)C)O.[Ca+2]

2.1.5 Isomeric SMILES

C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)[O-])C(=O)N)N(C)C)O.C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)[O-])C(=O)N)N(C)C)O.[Ca+2]

2.2 Other Identifiers

2.2.1 UNII

NR4B2SX17S

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Calcium Chlortetracycline

2. Chlorotetracycline Calcium Salt

3. Calcium-chlortetracycline Complex

4. Chlortetracycline Calcium Complex

5. Nr4b2sx17s

6. Chlortetracycline Calcium Complex [green Book]

7. 57122-99-3

8. 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Calcium Salt

9. Chlortetracycline Calcium [who-dd]

10. Unii-nr4b2sx17s

11. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Calcium Salt (2:1), (4s-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-

12. Q27285004

13. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Calcium Salt (2:1), (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-

2.4 Create Date

2015-02-20

3 Chemical and Physical Properties

Molecular Formula	C₄₄H₄₄CaCl₂N₄O₁₆
Molecular Weight	995.8 g/mol
Hydrogen Bond Donor Count	10
Hydrogen Bond Acceptor Count	18
Rotatable Bond Count	4
Exact Mass	994.1755276 g/mol
Monoisotopic Mass	994.1755276 g/mol
Topological Polar Surface Area	369 Å²
Heavy Atom Count	67
Formal Charge	0
Complexity	1010
Isotope Atom Count	0
Defined Atom Stereocenter Count	10
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3